logo
Select company
Select metric
-0.79%Shareholder Yield
VS
Market
39
Sector
59
Industry
70
History
94
$ 9.96Close
$ 2.51 - $ 9.97 52-Week Range
Ticker Information

Ticker

FDMT

Company Name

4D MOLECULAR THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

4D MOLECULAR THERAPEUTICS INC - Shareholder Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FDMT - Shareholder Yield Historical data
DateMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity SharesNet Cash Flow - Issuance (Repayment) of Debt SecuritiesNet Cash Flow - Dividends & Other Cash DistributionsShareholder Yield
6/30/2025$ 258.26M$ 2.03M$ 0$ 0-0.79%
3/31/2025$ 150.09M$ 18.42M$ 0$ 0-12.27%
12/31/2024$ 209.75M$ 337.25M$ 0$ 0-160.79%
9/30/2024$ 356.42M$ 341.41M$ 0$ 0-95.79%
6/30/2024$ 765.51M$ 350.86M$ 0$ 0-45.83%
3/31/2024$ 1.33B$ 464.6M$ 0$ 0-35.05%
12/31/2023$ 1.39B$ 156.83M$ 0$ 0-11.24%
9/30/2023$ 448.91M$ 154.58M$ 0$ 0-34.44%
6/30/2023$ 716.58M$ 144.67M$ 0$ 0-20.19%
3/31/2023$ 562.1M$ 13.74M$ 0$ 0-2.44%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • 4D MOLECULAR THERAPEUTICS INC's latest trailing twelve months (TTM) Shareholder Yield stands at -19.57%.
  • Over the past 5 years, 4D MOLECULAR THERAPEUTICS INC's average Shareholder Yield has been -35.73%.
  • The median Shareholder Yield for 4D MOLECULAR THERAPEUTICS INC during this period was -26.29%
  • 4D MOLECULAR THERAPEUTICS INC reached its highest Shareholder Yield over the past 5 years at -0.62%.
  • The lowest Shareholder Yield recorded by 4D MOLECULAR THERAPEUTICS INC in the same timeframe -160.79%

4D MOLECULAR THERAPEUTICS INC's Shareholder Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Shareholder Yield Benchmarks
CompanyShareholder Yield
ALT : ALTIMMUNE INC -30.58%LYEL : LYELL IMMUNOPHARMA INC -0.31%LXEO : LEXEO THERAPEUTICS INC -28.15%NMRA : NEUMORA THERAPEUTICS INC -13.81%ANNX : ANNEXON INC -2.05%DMAC : DIAMEDICA THERAPEUTICS INC -0.18%AARD : AARDVARK THERAPEUTICS INC -AVIR : ATEA PHARMACEUTICALS INC 5.22%GALT : GALECTIN THERAPEUTICS INC -9.88%JBIO : JADE BIOSCIENCES INC -79.94%

Definition of Shareholder Yield

[Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for 4D MOLECULAR THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 206.51M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.06B ]
(=) Shareholder Yield [ -19.57% ]

FDMT - Shareholder Yield, Last 5 years

-160.79%

Minimum

Dec 31, 2024

-0.62%

Maximum

Dec 31, 2022

-35.73%

Average

-26.29%

Median

Shareholder Yield Benchmark Analysis

The chart above depicts the distribution of Shareholder Yield for companies in the Total Stock Market. The average Shareholder Yield of the companies is 0.58% with a standard deviation of 11.13%.
The following table provides additional summary stats:
Shareholder Yield in the Market:
filtered constituents3.49K
min-33.43%
max34.45%
average0.58%
median1.07%
std11.13%